Commerzbank AG
Commerzbank AG (CRZBY) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Commerzbank AG (CRZBY), featuring income statements, balance sheets, and cash flow data.
Commerzbank AG (CRZBY) Income Statement & Financial Overview
View the income breakdown for Commerzbank AG CRZBY across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.87B | $7.15B | $5.41B | $6.74B |
| Cost of Revenue | $2.81B | $3.03B | $3.28B | $3.37B |
| Gross Profit | $3.06B | $2.74B | $2.13B | $3.37B |
| Gross Profit Ratio | $0.52 | $0.38 | $0.39 | $0.50 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $2.48B | $36.00M | $36.00M |
| Operating Expenses | $1.88B | $2.48B | $1.25B | $2.07B |
| Total Costs & Expenses | $4.68B | $6.15B | $4.53B | $5.87B |
| Interest Income | $4.88B | $5.11B | $5.33B | $5.45B |
| Interest Expense | $2.81B | $3.03B | $3.28B | $3.37B |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | -$871.00M |
| EBITDA | $1.19B | $996.00M | $884.00M | $870.00M |
| EBITDA Ratio | $0.20 | $0.14 | $0.16 | $0.13 |
| Operating Income | $1.19B | $1.63B | $884.00M | $870.00M |
| Operating Income Ratio | $0.20 | $0.23 | $0.16 | $0.13 |
| Other Income/Expenses (Net) | $0.00 | -$637.00M | -$3.00M | -$1.61B |
| Income Before Tax | $1.19B | $996.00M | $884.00M | $870.00M |
| Income Before Tax Ratio | $0.20 | $0.14 | $0.16 | $0.13 |
| Income Tax Expense | $306.00M | $182.00M | $196.00M | $289.00M |
| Net Income | $834.00M | $751.00M | $641.00M | $538.00M |
| Net Income Ratio | $0.14 | $0.11 | $0.12 | $0.08 |
| EPS | $0.73 | $0.61 | $0.54 | $0.45 |
| Diluted EPS | $0.73 | $0.47 | $0.54 | $0.45 |
| Weighted Avg Shares Outstanding | $1.14B | $1.15B | $1.18B | $1.19B |
| Weighted Avg Shares Outstanding (Diluted) | $1.14B | $1.15B | $1.18B | $1.19B |
Over the past four quarters, Commerzbank AG demonstrated steady revenue growth, increasing from $6.74B in Q2 2024 to $5.87B in Q1 2025. Operating income reached $1.19B in Q1 2025, maintaining a consistent 20% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.19B, reflecting operational efficiency. Net income rose to $834.00M, with EPS at $0.73. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan